INFUSYSTEM HOLDINGS, INC Proceeds from Long-Term Debt Issued
INFUSYSTEM HOLDINGS, INC (INFU) reported Proceeds from Long-Term Debt Issued of $76.19 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-03-15
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $1.50M, a 173.59% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for the quarter ending 2017-12-31 was $549.00K.
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for the quarter ending 2017-09-30 was $9.21M.
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for the quarter ending 2017-06-30 was $15.01M.
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for fiscal 2021 was $76.19M, a 102.71% increase from fiscal 2020.
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for fiscal 2020 was $37.59M, a 298.34% increase from fiscal 2019.
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for fiscal 2019 was $9.44M, a 15.46% decline from fiscal 2018.
- INFUSYSTEM HOLDINGS, INC proceeds from issuance of long-term debt for fiscal 2018 was $11.16M, a 61.33% decline from fiscal 2017.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $76.19M 10-K · filed 2022-03-15 | |||
| 2020-12-31 | $37.59M 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $9.44M 10-K · filed 2022-03-15 | |||
| 2018-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $11.16M 10-K · filed 2019-03-22 | ||
| 2018-09-30 | $9.66M 10-Q · filed 2018-11-13 | |||
| 2017-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $9.76M derived: sum of 2 quarters · filed 2019-03-22 | $24.77M derived: sum of 3 quarters · filed 2019-03-22 | $28.87M 10-K · filed 2019-03-22 |
| 2017-09-30 | $9.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $24.22M derived: sum of 2 quarters · filed 2018-11-13 | $28.32M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $15.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $19.11M 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $4.10M 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | $66.89M 10-K · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |